DMSO Cryopreserved Platelets in Cardiopulmonary Bypass Surgery (CRYPTICS)
Public ClinicalTrials.gov record NCT04709705. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Controlled Trial Comparing Dimethyl Sulfoxide Cryopreserved Platelets to Liquid Stored Platelets in Patients Undergoing Cardiopulmonary Bypass Surgery (CRYPTICS)
Study identification
- NCT ID
- NCT04709705
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Cellphire Therapeutics, Inc.
- Industry
- Enrollment
- 161 participants
Conditions and interventions
Conditions
Interventions
- Human platelets Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 26, 2021
- Primary completion
- May 7, 2025
- Completion
- May 7, 2025
- Last update posted
- Sep 30, 2025
2021 – 2025
United States locations
- U.S. sites
- 16
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35205 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| George Washington University | Washington D.C. | District of Columbia | 20037 | — |
| UF Health | Gainesville | Florida | 32608 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Johns Hopkins University | Baltimore | Maryland | 21218 | — |
| Dartmouth Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Duke University Hospital | Durham | North Carolina | 27710 | — |
| The Ohio State Univ. Wexner Medical Center | Columbus | Ohio | 43210 | — |
| OU Medical Center | Oklahoma City | Oklahoma | 73104 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Thomas Jefferson Univ. Hospital | Philadelphia | Pennsylvania | 19107 | — |
| University of Virginia Medical Center | Charlottesville | Virginia | 22908 | — |
| Inova Cardiac Vascular | Falls Church | Virginia | 22042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04709705, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 30, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04709705 live on ClinicalTrials.gov.